Authors:
WITHOLD W
KOENIG S
KRUEMPELBECK G
BECKMANN MW
Citation: W. Withold et al., CLINICAL VALIDITY OF AN AUTOMATED IMMUNOASSAY FOR DETERMINATION OF BETA-CROSSLAPS(TM) IN HUMAN URINE SAMPLES, Clinical chemistry, 44, 1998, pp. 712-712
Authors:
WITHOLD W
FINK B
SCHMIDTGAYK H
BECKMANN MW
Citation: W. Withold et al., COMPARISON BETWEEN URINARY DEOXYPYRIDINOLINE AND SERUM BONE SIALOPROTEIN IN THE ASSESSMENT OF BONE-RESORPTION IN PATIENTS WITH RHEUMATIC DISEASES, Clinical chemistry, 44, 1998, pp. 715-715
Authors:
WITHOLD W
ARNING M
SCHWARZ M
WOLF HH
SCHNEIDER W
Citation: W. Withold et al., MONITORING OF MULTIPLE-MYELOMA PATIENTS BY SIMULTANEOUSLY MEASURING MARKER SUBSTANCES OF BONE-RESORPTION AND FORMATION, Clinica chimica acta, 269(1), 1998, pp. 21-30
Authors:
WITHOLD W
FINK B
FEIZELMEIER W
RUETHER W
BECKMANN MW
SCHMIDTGAYK H
Citation: W. Withold et al., SIMULTANEOUS ASSESSMENT OF PYRIDINOLINE IN SYNOVIAL-FLUID AND URINE SAMPLES FROM PATIENTS WITH OSTEOARTHRITIS OF THE KNEE, Clinical chemistry, 43, 1997, pp. 191-191
Citation: W. Withold et al., SERUM BONE ALKALINE-PHOSPHATASE IS SUPERIOR TO OSTEOCALCIN IN THE DETECTION OF METASTATIC SPREAD INTO BONE, Clinical chemistry, 43, 1997, pp. 545-545
Citation: W. Withold et al., SERUM BONE ALKALINE-PHOSPHATASE IS SUPERIOR TO PLASMA-LEVELS OF BONE-MATRIX PROTEINS FOR ASSESSMENT OF BONE METABOLISM IN PATIENTS RECEIVING RENAL-TRANSPLANTS, Clinica chimica acta, 261(2), 1997, pp. 105-115
Authors:
WITHOLD W
WOLF HH
KOLLBACH S
HEYLL A
SCHNEIDER W
REINAUER H
Citation: W. Withold et al., RELATIONSHIP BETWEEN BONE METABOLISM AND PLASMA CYTOKINE LEVELS IN PATIENTS AT RISK OF POSTTRANSPLANTATION BONE-DISEASE AFTER BONE-MARROW TRANSPLANTATION, European journal of clinical chemistry and clinical biochemistry, 34(4), 1996, pp. 295-299
Authors:
WITHOLD W
WOLF HH
KOLLBACH S
HEYLL A
SCHNEIDER W
REINAUER H
Citation: W. Withold et al., MONITORING OF BONE METABOLISM AFTER BONE-MARROW TRANSPLANTATION BY MEASURING 2 DIFFERENT MARKERS OF BONE TURNOVER, European journal of clinical chemistry and clinical biochemistry, 34(3), 1996, pp. 193-197
Citation: W. Withold, MONITORING OF BONE TURNOVER - BIOLOGICAL, PREANALYTICAL AND TECHNICALCRITERIA IN THE ASSESSMENT OF BIOCHEMICAL MARKERS, European journal of clinical chemistry and clinical biochemistry, 34(10), 1996, pp. 785-799
Authors:
WITHOLD W
FRIEDRICH W
DEGENHARDT S
GRABENSEE B
REINAUER H
Citation: W. Withold et al., COMPARISON BETWEEN PLASMA OSTEONECTIN LEVELS AND SERUM BONE ALKALINE-PHOSPHATASE MASS CONCENTRATIONS AS MARKERS OF BONE-FORMATION, Clinical chemistry, 42(6), 1996, pp. 55-55
Authors:
HEINS M
HEINTZEN P
WITHOLD W
STRAUER BE
LESCHKE M
REINAUER H
Citation: M. Heins et al., DETERMINATION OF NOT-ANTIBODY BOUND DIGOXIN IN A PATIENT WITH DIGOXIN-INTOXICATION AND FAB-ANTIBODY THERAPY IN THE STAT-LABORATORY, Clinical chemistry, 42(6), 1996, pp. 542-542
Authors:
WITHOLD W
ARNING M
SCHWARZ M
WOLF HH
SCHNEIDER W
REINAUER H
Citation: W. Withold et al., MONITORING OF THERAPEUTIC OUTCOME IN PATIENTS WITH MULTIPLE-MYELOMA BY SIMULTANEOUSLY MEASURING 3 DIFFERENT BIOCHEMICAL MARKERS OF BONE METABOLISM, Clinical chemistry, 42(6), 1996, pp. 722-722
Citation: W. Withold et al., METHOD FOR DETERMINATION OF BONE ALKALINE-PHOSPHATASE ACTIVITY - ANALYTICAL PERFORMANCE AND CLINICAL USEFULNESS IN PATIENTS WITH METABOLIC AND MALIGNANT BONE-DISEASES, Clinical chemistry, 42(2), 1996, pp. 210-217
Citation: W. Withold et al., COMPARISON OF BIOCHEMICAL MARKERS OF BONE-RESORPTION IN PATIENTS WITHMETABOLIC AND MALIGNANT BONE-DISEASES, Annals of clinical biochemistry, 33, 1996, pp. 421-427
Authors:
WITHOLD W
GEORGESCU G
KHAKZAD H
VOSBERG H
MUELLERGAERTNER HW
REINAUER H
Citation: W. Withold et al., SIMULTANEOUS ASSESSMENT OF BONE-COLLAGEN SYNTHESIS AND DEGRADATION INPATIENTS WITH DIFFERENT MALIGNANT-TUMORS - COMPARISON WITH THE RESULTS OF TC-99M-METHYLENE BISPHOSPHONATE BONE-SCINTIGRAPHY, European journal of clinical chemistry and clinical biochemistry, 33(8), 1995, pp. 479-485
Citation: W. Withold et al., PERFORMANCE-CHARACTERISTICS OF DIFFERENT IMMUNOASSAYS FOR DETERMINATION OF PARATHYRIN (1-84) IN HUMAN PLASMA SAMPLES, European journal of clinical chemistry and clinical biochemistry, 33(5), 1995, pp. 307-313
Citation: M. Heins et al., STORAGE OF SERUM OR WHOLE-BLOOD SAMPLES - EFFECTS OF TIME AND TEMPERATURE ON 22 SERUM ANALYTES, European journal of clinical chemistry and clinical biochemistry, 33(4), 1995, pp. 231-238
Citation: W. Withold et H. Reinauer, AN IMMUNOBLOTTING PROCEDURE FOLLOWING AGAROSE-GEL ELECTROPHORESIS FORDETECTION OF BENCE-JONES PROTEINURIA COMPARED WITH IMMUNOFIXATION ANDQUANTITATIVE LIGHT-CHAIN DETERMINATION, European journal of clinical chemistry and clinical biochemistry, 33(3), 1995, pp. 135-138
Authors:
WITHOLD W
WOLFF T
DEGENHARDT S
REINAUER H
Citation: W. Withold et al., EVALUATION OF A RADIOIMMUNOASSAY FOR DETERMINATION OF CALCITRIOL IN HUMAN SERA EMPLOYING A I-125 LABELED TRACER, European journal of clinical chemistry and clinical biochemistry, 33(12), 1995, pp. 959-963
Authors:
WITHOLD W
DEGENHARDT S
HEINS M
GRABENSEE B
REINAUER H
Citation: W. Withold et al., MONITORING OF BONE-RESORPTION AFTER RENAL-TRANSPLANTATION BY MEASURING THE URINARY-EXCRETION OF PYRIDINIUM CROSS-LINKS, European journal of clinical chemistry and clinical biochemistry, 33(1), 1995, pp. 15-21
Authors:
PLUM J
WITHOLD W
BUSCH T
BRENNER K
REINAUER H
GRABENSEE B
Citation: J. Plum et al., INTRAPERITONEAL PRODUCTION OF INFLAMMATORY CYTOKINES AND THEIR SOLUBLE RECEPTOR FRACTIONS IN CAPD PATIENTS WITHOUT PERITONITIS, Kidney international, 47(3), 1995, pp. 994-994
Authors:
WITHOLD W
DEGENHARDT S
GRABENSEE B
REINAUER H
Citation: W. Withold et al., BONE ALKALINE-PHOSPHATASE (BAP) AND THE CARBOXY-TERMINAL PROPETIDE OFTYPE-I PROCOLLAGEN (PICP) IN PATIENTS FOLLOWING RENAL-TRANSPLANTATION, Clinical chemistry, 41(6), 1995, pp. 44-45